Literature DB >> 6117127

Electroconvulsive shock increases tyrosine hydroxylase activity in the brain and adrenal gland of the rat.

J M Masserano, G S Takimoto, N Weiner.   

Abstract

A single application of electroconvulsive shock produced a rapid but short-lasting increase in tyrosine hydroxylase activity above control values in the rat adrenal medulla and striatum. After repeated electroconvulsive shock treatment (once per day for 7 days), tyrosine hydroxylase activity increased significantly in the locus ceruleus, nucleus of the tractus solitarius, hippocampus, cerebellum, and frontal cortex and remained elevated for 4 to 8 days. Adrenal tyrosine hydroxylase activity increased 1 day after the termination of repeated electroconvulsive shock treatments and remained elevated for at least 24 days, possibly reflecting the establishment of a new and higher steady-state level of catecholamine biosynthesis in the adrenal. These findings suggest that the persistent changes in tyrosine hydroxylase activity produced by repeated electroconvulsive shock may be a factor contributing to the long-lasting antidepressant effects of this treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6117127     DOI: 10.1126/science.6117127

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety.

Authors:  Soyong Jang; Donghyun Kim; Yeonju Lee; Sohyeon Moon; Seikwan Oh
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

2.  Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens.

Authors:  G G Nomikos; A P Zis; G Damsma; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Electroconvulsive shock increases preproenkephalin messenger RNA abundance in rat hypothalamus.

Authors:  K Yoshikawa; J S Hong; S L Sabol
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  Methamphetamine potentiates behavioral and electrochemical responses after mild traumatic brain injury in mice.

Authors:  Hui Shen; Brandon K Harvey; Yung-Hsiao Chiang; Chaim G Pick; Yun Wang
Journal:  Brain Res       Date:  2010-10-13       Impact factor: 3.252

5.  Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.

Authors:  A Reches; H R Wagner; A I Barkai; V Jackson; E Yablonskaya-Alter; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients.

Authors:  Tomasz Gos; Dieter Krell; Hendrik Bielau; Ralf Brisch; Kurt Trübner; Johann Steiner; Hans-Gert Bernstein; Zbigniew Jankowski; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

Review 7.  Tyrosine hydroxylase regulation in the central nervous system.

Authors:  J M Masserano; N Weiner
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

8.  Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications.

Authors:  L S Brady; A B Lynn; J R Glowa; D Q Le; M Herkenham
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus.

Authors:  E J Nestler; A McMahon; E L Sabban; J F Tallman; R S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

10.  Enhancement of Anxiety and Modulation of TH and pERK Expressions in Amygdala by Repeated Injections of Corticosterone.

Authors:  Heena Lim; Soyong Jang; Yeonju Lee; Sohyeon Moon; Jieun Kim; Seikwan Oh
Journal:  Biomol Ther (Seoul)       Date:  2012-07       Impact factor: 4.634

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.